Frank Dunphy

5.8k citations
65 papers · 3.7k · 2 hit papers · h-index 25

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Neutropenia and Cancer Infections

Papers in

    • Lung Cancer Research Studies 6
    • Neutropenia and Cancer Infections 6
    • Cancer Treatment and Pharmacology 6
    • Head and Neck Cancer Studies 11

Frank Dunphy

65 papers receiving 3.6k citations

Frank Dunphy's Hit Papers

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study 2016 · 507 citations
5070+8+17Years since publication2505007501000

Peers

Frank Dunphy
Comparison fields: 5 of 90
  • Otorhinolaryngology 348
  • Oncology 1.6k
  • Pulmonary and Respiratory Medicine 1.7k
  • Hematology 312
  • Cancer Research 356
Replace Francisco Robert with:
Francisco Robert United States
Meredith A. Goldwasser United States
D. Scott Ernst Canada
Antonio López–Pousa Spain
Thomas J. Ervin United States
Jean-Pascal Machiels Belgium
Andreas Schalhorn Germany
E Vélez-García United States
Hanne Sand Hansen Denmark
P. Lianes Spain
Frank Dunphy relative to Francisco Robert United States Francisco Robert's profile →
Citations per field
00.5×2.5×
Francisco Robert · 1×
Citations per year

Countries citing papers authored by Frank Dunphy

Since Specialization
Citations

This map shows the geographic impact of Frank Dunphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Dunphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Dunphy more than expected).

Fields of papers citing papers by Frank Dunphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Dunphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Dunphy. The network helps show where Frank Dunphy may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Dunphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Dunphy Line = papers co-authored together Frank Dunphy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
Hit paper breakdown →
20001123
2
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Hit paper breakdown →
2016507
3 2015252
4 2000178
5 1990145
6 1997117
7 1994110
8 2014100
9 199479
10 201270
11 201268
12 201765
13 199760
14 200158
15 199751
16 199647
17 199043
18 199941
19 200133
20 199733

About Frank Dunphy

Frank Dunphy is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Hematology and Molecular Biology, having authored 65 papers that have together received 3.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (11 papers), Lung Cancer Treatments and Mutations (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lung Cancer Research Studies (6 papers), Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Otorhinolaryngology (348 citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.7k citations), Hematology (312 citations) and Cancer Research (356 citations). Frank Dunphy has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Mark G. Kris, Jeffrey Crawford, James Boyd, Everett E. Vokes, David R. Gandara, Leonard Kalman, Daniel D. Karp, Luz Hammershaimb, F. Gamza and Jin Soo Lee. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Head & Neck, Journal of Thoracic Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact